National Library of Medicine classification

Darbepoetin Alfa (Aranesp) Global Market Research Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 23, 2023
Health, Pharmaceutical, FDA, Sale, Daprodustat, Ageing, National library, Anemia, Food, Epoetin alfa, Bone marrow, Prevalence, Conditional sentence, US Foods, Darbepoetin alfa, GSK plc, Cell, Chronic kidney disease, Growth, Dialysis, Chronic condition, Cancer, Patient, National Library of Medicine classification, Dietary supplement, Pharmaceutical industry

The "Darbepoetin Alfa (Aranesp) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Darbepoetin Alfa (Aranesp) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • The prevalence of chronic diseases is on the rise, and this trend is expected to drive the growth of the darbepoetin alfa market.
  • This substantial increase in the prevalence of chronic diseases is a significant driver of the darbepoetin alfa market.
  • Product innovation is a prominent trend in the darbepoetin alfa market, with major companies adopting new technologies to maintain their market positions.

Global Hormone Replacement Therapy Market 2022: A $25+ Billion Market by 2027 - Industry Trends, Growth, Impact of Inflation, Opportunities, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Health, Pharmaceutical, Disease, Ageing, Pfizer, HRT, National Library of Medicine classification, Osteoporosis, UN, Hormone replacement therapy, Health Canada, Availability, Menopause, Flash, Estradiol, Fatigue, Risk, Muscle, Thyroid, Drug development, Degenerative disease, Woman, Weight gain, Patient, Prevalence, Mindfulness, National library, Uterus, Hypothyroidism, Prescription, Disorder, Theramex, Progesterone, Growth hormone, Incidence, Breast cancer, Pharmaceutical industry, Birth control, Frontier, Type, Growth, Testosterone

The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Global Hormone Replacement Therapy Market is expected to reach US$ 25.09 Billion by 2027 from US$ 18.04 Billion in 2022, growing with a CAGR of 6.82% during 2022-2027.
  • According to the UN, the global population will grow by 8.5 billion in 2030 and 9.7 billion in 2050.
  • Based on Type, hormone replacement therapy is categorized into Estrogen, Human Growth, Thyroid, Testosterone, and Progestogen.

The Worldwide Arterial Cannula Industry is Projected to Reach $33.4 Billion by 2030: Rising Number of Surgical Procedures and Advancements in Minimally Invasive Surgeries Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 30, 2022
Health, General Health, National Library of Medicine classification, 3D ultrasound, COVID-19, USD, Hospital, Growth, Patient, National library, Investment, Conditional sentence, Prevalence, ECMO, Pharmaceutical industry

The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.2% over the forecast period.

Key Points: 
  • The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.2% over the forecast period.
  • An increase in the prevalence of chronic diseases is leading to a rise in surgical procedures, which is driving the growth of the industry.
  • Minimally invasive techniques and cutting-edge technology give patients fast recovery time, less pain, and the best aesthetic results.
  • Moreover, increasing investments in the healthcare sector are also expected to boost the overall industry growth over the forecast period.

Global Diagnostic Imaging Market Forecast Report 2022: A $53 Billion Market by 2028 - Artificial Intelligence (AI) and Analytics Gaining Traction - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 1, 2022
Radiology, Health, Mortality, Software, Osteoporosis, Partnership, COVID-19, Conditional sentence, Degenerative disease, Nvidia, Cancer, Hospital, Ageing, Falls, Publication, Modality, ICT, National library, Journal of Medical Internet Research, WHO, Life expectancy, Artificial intelligence, Solution, Death, Man, Hospital Insurance and Diagnostic Services Act, CT, Magnetic resonance imaging, Diagnosis, Fracture, Medical imaging, UNICEF, Center, Disability, Google Images, Prevalence, Stroke, Population, Korea Disease Control and Prevention Agency, MRI, Siemens Healthineers, Diabetes, Woman, National Library of Medicine classification, Chronic condition, CDC, AI, Health, Medical device

The "Diagnostic Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality, Application, and End-user" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diagnostic Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality, Application, and End-user" report has been added to ResearchAndMarkets.com's offering.
  • The global diagnostic imaging market is projected to reach US$ 53,410.59 million by 2028 from US$ 38,034.56 million in 2022.
  • Also, the use of Artificial Intelligence (AI) and analytics in diagnostic imaging equipment would act as a future trend in the global diagnostic imaging market.
  • Additionally, the WHO and its partners provide training programs on the use and management of diagnostic imaging, focusing on patient safety.

Global Autotransfusion Devices Market Forecast to 2028: Technological Developments & Elevated Healthcare Expenditure in Emerging Economies Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 26, 2022
Technology, Health, Other Technology, Medical Devices, Severe acute respiratory syndrome coronavirus 2, LivaNova, National Library of Medicine classification, Conditional sentence, Medicine, Traction, BD, Patient, Elective surgery, National library, COVID-19, Industry, British Journal of Surgery, Transplant, Hospital, Heart, HOB GmbH & Co KG, Face, CAGR, Medtronic, Pharmaceutical industry, Health insurance

The "Autotransfusion Devices Market Forecast to 2028- COVID-19 Impact and Global Analysis - by Type; Application; End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Autotransfusion Devices Market Forecast to 2028- COVID-19 Impact and Global Analysis - by Type; Application; End User" report has been added to ResearchAndMarkets.com's offering.
  • The rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are contributing to the autotransfusion devices market growth.
  • The rapid spread of the COVID-19 pandemic has provided significant momentum to the autotransfusion device industry in 2020.
  • Thus, the overall COVID-19 impact on autotransfusion devices market is negative but the market is again gaining traction and expected to grow in coming years.

Global Homocystinuria Market Analysis/Forecast Report 2021-2028: Opportunities with Pyridoxine as a First-Line Agent for Homocystinuria - ResearchAndMarkets.com

Retrieved on: 
Monday, February 28, 2022
Health, Other Health, Lists of diseases, Diagnosis, Phenylketonuria, Degenerative disease, Growth, Prevalence, Laboratory, Betaine, Awareness, National library, Gaucher's disease, COVID-19, Pyridoxine, Method, Genetic testing, Hospital, Homocystinuria, Disorder, Treatment, Glycogen, National Library of Medicine classification, Academy, Geography, CAGR, Research, Pharmaceutical industry, Medical device

The growth of the market is attributed to the rising deficiencies of vitamin B6 and vitamin B12 and the growing prevalence of inherited metabolic disorders.

Key Points: 
  • The growth of the market is attributed to the rising deficiencies of vitamin B6 and vitamin B12 and the growing prevalence of inherited metabolic disorders.
  • However, the lack of awareness about various rare disorders and inherited metabolic disorders hampers the market growth.
  • Lysosomal, storage disorder, Gaucher disease, phenylketonuria, glycogen storage diseases, mitochondrial disorders, and homocystinuria are a few inherited metabolic disorders.
  • Thus, the increase in the prevalence of inherited metabolic disorders is expected to boost the growth of the homocystinuria market worldwide.